Bill
Bill > S01795
NY S01795
NY S01795Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
summary
Introduced
01/13/2025
01/13/2025
In Committee
01/07/2026
01/07/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 General Assembly
Bill Summary
AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine autoinjectors for dispensation by pharmacists
AI Summary
This bill allows pharmacists to substitute a brand name epinephrine auto-injector (such as an EpiPen) with an alternate epinephrine auto-injector under specific conditions. These conditions include: the prescriber has not indicated that the specific brand must be dispensed, the alternate auto-injector is less expensive for the purchaser, the pharmacist has advised the patient about the alternate option and obtained their consent, and the pharmacist has provided counseling on how to use the new device. An epinephrine auto-injector is a medical device used to quickly deliver a dose of epinephrine (adrenaline) in emergency situations, typically for people experiencing severe allergic reactions (anaphylaxis). The bill amends the education law to give pharmacists more flexibility in providing potentially more affordable alternatives to patients while ensuring patient safety through consent and counseling requirements. The legislation takes effect immediately upon passage.
Committee Categories
Education
Sponsors (3)
Last Action
REFERRED TO HIGHER EDUCATION (on 01/07/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2025/S1795 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=S01795&term=2025&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#S01795 |
Loading...